Hypoxia-inducible factor-targeting prodrug TOP3 combined with gemcitabine or TS-1 improves pancreatic cancer survival in an orthotopic model
about
Hypoxia-inducible factor-targeting prodrug TOP3 combined with gemcitabine or TS-1 improves pancreatic cancer survival in an orthotopic model
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hypoxia-inducible factor-targe ...... urvival in an orthotopic model
@en
Hypoxia-inducible factor-targe ...... rvival in an orthotopic model.
@nl
type
label
Hypoxia-inducible factor-targe ...... urvival in an orthotopic model
@en
Hypoxia-inducible factor-targe ...... rvival in an orthotopic model.
@nl
prefLabel
Hypoxia-inducible factor-targe ...... urvival in an orthotopic model
@en
Hypoxia-inducible factor-targe ...... rvival in an orthotopic model.
@nl
P2093
P2860
P356
P1433
P1476
Hypoxia-inducible factor-targe ...... urvival in an orthotopic model
@en
P2093
Ngoc Thi Hong Hoang
Shinae Kizaka-Kondoh
Tetsuya Kadonosono
P2860
P304
P356
10.1111/CAS.12982
P577
2016-07-21T00:00:00Z